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I  genuinely  enjoyed  reading  the  excellent  and  in-
formative original article by Keshvari and colleagues 
in your journal recently.
1 Patients with hemophilia are 
at greater risk for all forms of viral hepatitis, especial-
ly hepatitis C than other patients.
2 The prevalence of 
hepatitis C virus (HCV) infection in Iranian patients 
with hemophilia was from 15.6% in Fars to 76.7% in 
North-West  of  Iran.
3 Recently,  a  meta-analysis  was 
done  by  Alavian  et  al.  and  demonstrated  that  the 
prevalence rate of HCV infection among Iranian he-
mophilic patients was almost 40.8%.
4 The HCV geno-
types and subtypes should be determined before start-
ing any treatment for HCV infection, as it determines 
the  selection  of  a  proper  antiviral  therapy,  and  the 
duration of treatment too.
5 
According to the Keshvari et al. article,
1 the most 
frequent HCV genotype was 1a (58%), followed by 
genotype  3a  (18.5%),  genotype  1b  (14.7%),  and 
mixed  HCV  genotypes  were  detected  in  6.2%  of 
cases. These findings were compatible with previous 
studies in Iran.
6-8 The pattern of HCV genotypes in 
their  patients  was  similar  to  Western  Europe  and 
different to Middle East countries, thus the author 
denotes to this pattern of HCV genotype in Iran due 
to probable use of clotting factors from Europe be-
fore 1987.  
In their study, there was no association between 
HCV genotypes and viral load, liver biochemical pro-
files, and splenomegaly although these findings were 
corresponded to other studies about this association. 
The sample size of study was high (367 hemophilic 
patients with clinically and laboratory proven chronic 
HCV  infection),  and  complete  information  on  sub-
jects were reported including bleeding disorder types, 
demographic  parameters,  biochemical  profile  that 
were well summarized in the tables.  
There are some problems in design of some tables 
such as Table 1. It would be better that the title of 
each category (Bleeding disorder type, Bleeding se-
verity, Laboratory parameters, HCV genotypes, Sple-
nomegaly) to be distinguishable from their subcatego-
ry, but regarding Table 2 and 3, they were good orga-
nized. However, these small problems cannot reduce 
the value of this article. As we evaluated the HCV 
genotypes in 8759 Iranian HCV infected patients (In 
Press), showing that subtype 1a was the most frequent 
one in patients less than 40 years (39% vs. 36.4%) 
and subtype 3a was the most frequent in patients old-
er than 40 years (33% vs. 29.1%). It is better to ana-
lyze the HCV genotypes in hemophilia patients while 
considering the age too. Finally, I appreciate this ab-
solutely perfect and informative article on genotyping 
of HCV in Iranian patients with hemophilia that can 
enhance and improve our knowledge about this dis-
ease in our country. 
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